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Background: Bariatric surgery carries a risk of severe postoperative complications, sometimes leading to
reinterventions or even death. The incidence and risk factors for reintervention and death within 90 days
after bariatric surgery are unclear, and were examined in this study.
Methods: This population-based cohort study included all patients who underwent bariatric surgery in
one of the five Nordic countries between 1980 and 2012. Data on surgical and endoscopic procedures,
diagnoses and mortality were retrieved from national high-quality and complete registries. Multivariable
Cox regression analysis was used to calculate hazard ratios (HRs), adjusted for country, age, sex,
co-morbidity, type of surgery and approach, year and hospital volume of bariatric surgery.
Results: Of 49977 patients, 1111 (2⋅2 per cent) had a reintervention and 95 (0⋅2 per cent) died within
90days of bariatric surgery. Risk factors for the composite outcome reintervention/mortality were older
age (HR 1⋅65, 95 per cent c.i. 1⋅36 to 2⋅01, for age at least 50 years versus less than 30 years) and
co-morbidity (HR 2⋅66, 1⋅53 to 4⋅62, for Charlson co-morbidity index score 2 or more versus 0). The risk
of reintervention/mortality was decreased for vertical banded gastroplasty compared with gastric bypass
(HR 0⋅37, 0⋅28 to 0⋅48) and more recent surgery (HR 0⋅51, 0⋅39 to 0⋅67, for procedures undertaken in
2010 or later versus before 2000). Sex, surgical approach (laparoscopic versus open) and hospital volume
did not influence risk of reintervention/mortality, but laparoscopic surgery was associated with a lower
risk of 90-day mortality (HR 0⋅29, 0⋅16 to 0⋅53).
Conclusion: Reintervention and death were uncommon events within 90days of bariatric surgery even
in this unselected nationwide cohort from five countries. Older patients with co-morbidities have an
increased relative risk of these outcomes.
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Introduction
Obesity, defined by a BMI of at least 30 kg/m2, occurred
in over 600 million adults in the world in 2015, and the
prevalence continues to increase1. The main treatments
are lifestyle interventions and medication, but bariatric
surgery is considered an effective treatment for severe
obesity2. Compared with non-surgical treatment, bariatric
surgery in severely obese patients is associated with better
survival and lower prevalence of cardiovascular diseases
and diabetes during the early postoperative years3–11,
although the relative mortality might increase again in the
long term12. These positive outcomes have contributed
to a rapid increase in bariatric surgery. However, bariatric
surgery carries a risk of severe postoperative complica-
tions, including those leading to reintervention and even
death13,14.
Some risk factors for 30-day reintervention and mor-
tality have been suggested, including older age, male sex,
tobacco smoking, high ASA fitness grade, co-morbidity,
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poor functional status and open surgery13,15–17. How-
ever, there is a lack of large-scale studies of unselected
(population-based) cohorts, and short-term outcomes
seem more relevant if assessed within 90 days rather than
30 days of upper gastrointestinal surgery18,19. Therefore,
the present study aimed to estimate the incidence of, and
identify risk factors for, reintervention or death within
90 days of bariatric surgery in a large and unselected
cohort. It was hypothesized that rates of postoperative re-
intervention or death would be increased in older patients
and men, patients with more co-morbidity, those who
underwent open surgery or types of bariatric surgery other
than gastric banding, and patients treated in lower-volume
hospitals or during earlier years.
Methods
This population-based cohort study covered the 33-year
interval between 1980 and 2012. The study examined
the rate of reintervention and all-cause mortality within
90 days of bariatric surgery using nationwide data from
well maintained health data registries in the five Nordic
countries: Denmark, Finland, Iceland, Norway and Swe-
den. The source cohort, the Nordic Obesity Surgery
Cohort (NordOSCO), has been described elsewhere20.
The first analytical study based on data from NordOSCo
examined bariatric surgery in relation to long-term
survival12. All Nordic countries have similar and virtually
complete records of hospital admissions and intervention
codes, including diagnoses and surgical and endoscopic
interventions21. Reporting of this information for each
patient to the national health data registries is mandat-
ory by law, and is linked to remuneration of the Nordic
hospitals21. Follow-up for mortality is complete for all res-
idents. At birth or on immigration, each Nordic resident
receives a unique personal identity code, which enabled
accurate linkage of individual data between registers for
each participant21–23. The study was approved by all rel-
evant ethical committees, data inspectorates and register
holders in each of the participating countries20.
Bariatric surgery cohort
The present study included individuals diagnosed with
obesity combined with a bariatric surgery code recorded
in any of the Nordic patient registries20. These registries
hold complete nationwide information on in-hospital care
and outpatient specialist care, including diagnoses and sur-
gical and endoscopic procedures. The concordance of the
diagnoses and procedures recorded in the patient registries
is generally high compared with patient records24–26, and
is very high (97 per cent concordant) for bariatric surgery
in particular27. The period of data retrieval varied between
the countries: from 1996 to 2011 in Denmark, 1996 to
2012 in Finland, 1999 to 2012 in Iceland, 2007 to 2011
in Norway, and 1980 to 2012 in Sweden. The indications
for bariatric surgery were similar among the participating
centres, and the countries shared clinical guidelines. The
bariatric procedures comprised mainly gastric bypass, fol-
lowed by gastric banding and vertical banded gastroplasty.
Sleeve gastrectomy was rarely performed in the Nordic
countries during the study interval and had no separate
code in the patient registries.
Potential risk factors
Seven potential risk factors were examined, categorized as
follows: age (less than 30, 30–39, 40–49 or at least 50 years
at the time of surgery), sex (male or female), co-morbidity
(Charlson co-morbidity index score 0, 1 or at least 2), type
of bariatric surgery (gastric bypass, vertical banded gastro-
plasty, gastric banding, malabsorptive procedures or other
bariatric procedures), surgical approach (open or laparo-
scopic), calendar year of surgery (before 2000, 2000–2009,
or 2010 or later) and hospital volume of surgery (in tertiles,
3 similar sized groups). The ten-year cut-off values for
age were chosen because the number in each group was
close to the quartiles. Co-morbidity was assessed using
the most recent and well validated version of the Charlson
co-morbidity index28. Diagnoses in the patient registries
recorded up to 1 year before entry into the cohort were
included to allow relevant co-morbidities to be included.
The type of bariatric surgery and surgical approach were
determined by the specific surgical codes in the patient
registries. ASA fitness grade was not available in the reg-
istries. The code representing other bariatric procedures
did not specify the type of bariatric surgery, but included
sleeve gastrectomies, balloon procedures and some com-
bined sleeve gastrectomy and duodenal switch procedures.
The malabsorptive procedure codes included biliopan-
creatic diversion, duodenal switch and jejunoileal bypass
procedures. Calculation of hospital volume of bariatric
surgery was possible for data from Finland, Iceland and
Sweden, because the hospital codes were available in these
countries in NordOSCO, but not for Denmark or Norway.
For each hospital and year, the annual hospital volume was
calculated as the mean of any bariatric surgery procedures
during the index year and previous 3 years in one specific
hospital. This strategy was chosen to reduce random
variations in the annual hospital volume variable29. If data
for fewer than 3 previous years were available, calculation
of the average was based on all available years.
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Table 1 Characteristics of 49 977 patients who underwent bariatric surgery in any of the five Nordic countries
Outcome within 90days of surgery
Bariatric surgery
(n =49977)
Reintervention/
mortality (n =1192)
Reintervention
(n =1111)
Mortality
(n =95)
Country
Denmark 3269 (6⋅5) 79 (6⋅6) 70 (6⋅3) 10 (11)
Finland 4429 (8⋅9) 118 (9⋅9) 114 (10⋅3) 5 (5)
Iceland 731 (1⋅5) 0 (0) 0 (0) 0 (0)
Norway 5507 (11⋅0) 93 (7⋅8) 84 (7⋅6) 9 (9)
Sweden 36041 (72⋅1) 902 (75⋅7) 843 (75⋅9) 71 (75)
Age (years)
<30 7815 (15⋅6) 148 (12⋅4) 143 (12⋅9) 5 (5)
30–39 14 388 (28⋅8) 291 (24⋅4) 275 (24⋅8) 17 (18)
40–49 15 922 (31⋅9) 382 (32⋅0) 361 (32⋅5) 28 (29)
≥50 11852 (23⋅7) 371 (31⋅1) 332 (29⋅9) 45 (47)
Sex
M 12730 (25⋅5) 331 (27⋅8) 296 (26⋅6) 40 (42)
F 37 247 (74⋅5) 861 (72⋅2) 815 (73⋅4) 55 (58)
Charlson co-morbidity index score
0 46648 (93⋅3) 1083 (90⋅9) 1021 (91⋅9) 74 (78)
1 3122 (6⋅3) 96 (8⋅0) 81 (7⋅3) 17 (18)
≥2 207 (0⋅4) 13 (1⋅1) 9 (0⋅8) 4 (4)
Type of bariatric surgery
Gastric bypass 36 678 (73⋅4) 875 (73⋅4) 822 (74⋅0) 64 (67)
Vertical banded gastroplasty 5487 (11⋅0) 155 (13⋅0) 140 (12⋅6) 17 (18)
Gastric banding 5450 (10⋅9) 78 (6⋅5) 71 (6⋅4) 7 (7)
Other bariatric procedures 1578 (3⋅2) 53 (4⋅4) 50 (4⋅5) 4 (4)
Malabsorptive procedures 784 (1⋅6) 31 (2⋅6) 28 (2⋅5) 3 (3)
Surgical approach
Open 13601 (27⋅2) 393 (33⋅0) 348 (31⋅3) 53 (56)
Laparoscopic 36 376 (72⋅8) 799 (67⋅0) 763 (68⋅7) 42 (44)
Year of surgery
Before 2000 9085 (18⋅2) 252 (21⋅1) 224 (20⋅2) 34 (36)
2000–2009 18725 (37⋅5) 504 (42⋅3) 469 (42⋅2) 38 (40)
2010 onwards 22 167 (44⋅4) 436 (36⋅6) 418 (37⋅6) 23 (24)
Hospital volume
Lowest (<7 operations) 1692 (3⋅4) 59 (4⋅9) 53 (4⋅8) 8 (8)
Medium (7–25 operations) 6590 (13⋅2) 154 (12⋅9) 140 (12⋅6) 14 (15)
Highest (≥26 operations) 32 919 (65⋅9) 807 (67⋅7) 764 (68⋅8) 54 (57)
Missing* 8776 (17⋅6) 172 (14⋅4) 154 (13⋅9) 19 (20)
No. of reinterventions
0 48866 (97⋅8) 81 (6⋅8) 0 (0⋅0) 81 (85)
1 1010 (2⋅0) 1010 (84⋅7) 1010 (90⋅9) 14 (15)
2 88 (0⋅2) 88 (7⋅4) 88 (7⋅9) 0 (0)
≥3 13 (0⋅03) 13 (1⋅1) 13 (1⋅2) 0 (0)
First reintervention†
Operative 813 (1⋅6) 813 (68⋅2) 813 (73⋅2) 13 (14)
Percutaneous drain 65 (0⋅1) 65 (5⋅5) 65 (5⋅8) 0 (0)
Tracheostomy 17 (0⋅03) 17 (1⋅4) 17 (1⋅5) 1 (1)
Endoscopic 295 (0⋅6) 295 (24⋅7) 295 (26⋅6) 0 (0)
Values in parentheses are percentages. *Hospital volume data were not available for Denmark and Norway. †Some reinterventions were done at the same
time.
© 2020 The Authors. British Journal of Surgery published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2020; 107: 1221–1230
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Table 2 Hazard ratios for the composite outcome
reintervention/mortality within 90days of bariatric surgery
No. of
patients with
outcome*
(n =1192)
Hazard
ratio for
reintervention/
mortality†‡
Age (years)
<30 148 (12⋅4) 1⋅00 (reference)
30–39 291 (24⋅4) 1⋅07 (0⋅88, 1⋅31)
40–49 382 (32⋅0) 1⋅29 (1⋅06, 1⋅56)
≥50 371 (31⋅1) 1⋅65 (1⋅36, 2⋅01)
Sex
M 331 (27⋅8) 1⋅00 (reference)
F 861 (82⋅2) 0⋅94 (0⋅83, 1⋅07)
Charlson co-morbidity index score
0 1083 (90⋅9) 1⋅00 (reference)
1 96 (8⋅1) 1⋅34 (1⋅09, 1⋅66)
≥2 13 (1⋅1) 2⋅66 (1⋅53, 4⋅62)
Type of bariatric surgery
Gastric bypass 875 (73⋅4) 1⋅00 (reference)
Vertical banded gastroplasty 155 (13⋅0) 0⋅73 (0⋅58, 0⋅92)
Gastric banding 78 (6⋅5) 0⋅37 (0⋅28, 0⋅48)
Other bariatric procedures 53 (4⋅4) 1⋅41 (1⋅05, 1⋅89)
Malabsorptive procedures 31 (2⋅6) 1⋅20 (0⋅82, 1⋅76)
Surgical approach
Open 393 (33⋅0) 1⋅00 (reference)
Laparoscopic 799 (67⋅0) 0⋅87 (0⋅73, 1⋅04)
Year of surgery
Before 2000 252 (21⋅1) 1⋅00 (reference)
2000–2009 504 (42⋅3) 0⋅77 (0⋅61, 0⋅97)
2010 onwards 436 (36⋅6) 0⋅51 (0⋅39, 0⋅67)
Hospital volume§
Lowest (<7 operations) 59 (5⋅8) 1⋅00 (reference)
Medium (7–25 operations) 154 (15⋅1) 0⋅70 (0⋅52, 0⋅95)
Highest (≥26 operations) 807 (79⋅1) 0⋅80 (0⋅61, 1⋅07)
Values in parentheses are *percentages and †95 per cent confidence inter-
vals. ‡Adjusted for country, age, sex, Charlson co-morbidity index, type
of surgery, surgical approach and year of surgery, but not the factor
being analysed. §Hospital volume analysis includes data only from Finland,
Iceland and Sweden, with categorization in tertiles, based onmean number
of procedures in that hospital during the past 4 years.
Outcomes
The primary outcome was the first occurrence of any
reintervention or death from any cause within the first
90 postoperative days. This composite outcome (reinter-
vention/mortality) was used to avoid bias owing to the
competing risk of mortality when examining the risk of
reintervention, that is patients might die from compli-
cations before reintervention was possible. Secondary
outcomes were the separate outcomes reintervention
within 90 days of surgery and all-cause 90-day mortality.
Subanalyses were conducted by type of reintervention:
Table 3 Stratified analyses for the composite outcome
reintervention/mortality within 90days of bariatric surgery for
co-variables with a statistically significant interaction
No. of
patients
with
outcome*
Hazard
ratio for
reintervention/
mortality†‡
Open surgical approach
Sex
M 132 (33⋅6) 1⋅00 (reference)
F 261 (66⋅4) 0⋅66 (0⋅54, 0⋅82)
Year of surgery
Before 2000 234 (59⋅5) 1⋅00 (reference)
2000–2009 130 (33⋅1) 0⋅73 (0⋅57, 0⋅94)
2010 or later 29 (7⋅4) 0⋅91 (0⋅60, 1⋅37)
Laparoscopic surgical approach
Sex
M 199 (24⋅9) 1⋅00 (reference)
F 600 (75⋅1) 1⋅13 (0⋅96, 1⋅33)
Year of surgery
Before 2000 18 (2⋅3) 1⋅00 (reference)
2000–2009 374 (46⋅8) 0⋅59 (0⋅36, 0⋅96)
2010 or later 407 (50⋅9) 0⋅37 (0⋅23, 0⋅61)
Surgery before 2000
Type of bariatric surgery
Gastric bypass 58 (82⋅9) 1⋅00 (reference)
Other bariatric procedures 12 (17⋅1) 0⋅61 (0⋅33, 1⋅13)
Surgery in 2000–2009
Type of bariatric surgery
Gastric bypass 417 (95⋅6) 1⋅00 (reference)
Other bariatric procedures 19 (4⋅4) 1⋅59 (1⋅00, 2⋅55)
Surgery in 2010 or later
Type of bariatric surgery
Gastric bypass 400 (94⋅8) 1⋅00 (reference)
Other bariatric procedures 22 (4⋅8) 2⋅01 (1⋅29, 3⋅15)
Values in parentheses are *percentages and †95 per cent confidence inter-
vals. ‡Adjusted for country, age, sex, Charlson co-morbidity index, type
of surgery, surgical approach and year of surgery, but not the factor being
analysed.
operative intervention, defined as any abdominal or thor-
acic invasive operation; endoscopic intervention, defined
as interventional endoscopy for bleeding, stenting or
dilatation, but not gastroscopy without other interven-
tion codes; percutaneous intervention; and tracheostomy
(included because it is a surgical intervention typically
needed because of postoperative complications). Data
for reinterventions were collected from the national
patient registries, using the relevant procedure codes
(Table S1, supporting information). Validation studies have
shown high completeness and accuracy of interventions
in the patient registries27,30,31. Dates and causes of death
were obtained from the national death registries until
© 2020 The Authors. British Journal of Surgery published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2020; 107: 1221–1230
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Table 4 Adjusted hazard ratios for reintervention or death within 90days, analysed separately, in obese individuals undergoing
bariatric surgery
Reintervention Mortality
No. with outcome*
(n =1111) Hazard ratio† ‡§
No. with outcome*
(n =95) Hazard ratio† ‡¶
Age (years)
<30 143 (12⋅9) 1⋅00 (reference) 5 (5) 1⋅00 (reference)
30–39 275 (24⋅8) 1⋅05 (0⋅86, 1⋅29) 17 (18) 1⋅89 (0⋅69, 5⋅13)
40–49 361 (32⋅5) 1⋅26 (1⋅04, 1⋅52) 28 (29) 2⋅76 (1⋅06, 7⋅18)
≥50 332 (29⋅9) 1⋅54 (1⋅26, 1⋅89) 45 (47) 5⋅57 (2⋅18, 14⋅24)
Sex
M 296 (26⋅6) 1⋅00 (reference) 40 (42) 1⋅00 (reference)
F 815 (73⋅4) 0⋅99 (0⋅86, 1⋅13) 55 (58) 0⋅57 (0⋅37, 0⋅86)
Charlson co-morbidity index score
0 1021 (91⋅9) 1⋅00 (reference) 74 (78) 1⋅00 (reference)
1 81 (7⋅3) 1⋅21 (0⋅96, 1⋅52) 17 (18) 3⋅27 (1⋅89, 5⋅67)
≥2 9 (0⋅8) 2⋅00 (1⋅03, 3⋅87) 4 (4) 9⋅48 (3⋅33, 26⋅99)
Type of bariatric surgery
Gastric bypass 822 (74⋅0) 1⋅00 (reference) 64 (67) 1⋅00 (reference)
Vertical banded gastroplasty 140 (12⋅6) 0⋅75 (0⋅59, 0⋅96) 17 (18) 0⋅43 (0⋅21, 0⋅86)
Gastric banding 71 (6⋅4) 0⋅38 (0⋅29, 0⋅50) 7 (7) 0⋅18 (0⋅08, 0⋅44)
Other bariatric procedures 50 (4⋅5) 1⋅48 (1⋅10, 2⋅01) 4 (4) 0⋅74 (0⋅26, 2⋅14)
Malabsorptive procedures 28 (2⋅5) 1⋅15 (0⋅84, 1⋅88) 3 (3) 0⋅48 (0⋅14, 1⋅62)
Surgical approach
Open 348 (31⋅3) 1⋅00 (reference) 53 (56) 1⋅00 (reference)
Laparoscopic 763 (68⋅7) 0⋅95 (0⋅78, 1⋅14) 42 (44) 0⋅29 (0⋅16, 0⋅53)
Year of surgery
Before 2000 224 (20⋅2) 1⋅00 (reference) 34 (36) 1⋅00 (reference)
2000–2009 469 (42⋅2) 0⋅80 (0⋅63, 1⋅02) 38 (40) 0⋅35 (0⋅17, 0⋅71)
2010 or later 418 (37⋅6) 0⋅54 (0⋅41, 0⋅71) 23 (24) 0⋅20 (0⋅09, 0⋅47)
Values in parentheses are *percentages and †95 per cent confidence intervals. ‡Adjusted for country, age, sex, Charlson co-morbidity index, type of surgery,
surgical approach and year of surgery, but not the factor being analysed. §Censored at death or after 90 days; ¶censored after 90 days.
31 December, 2012. The completeness of all-cause
mortality data in these registers is 100 per cent32–34.
Statistical analysis
Patients entered the study at the time of bariatric surgery
and remained until reintervention, death, emigration
(unlikely within 90 days of surgery) or end of follow-up
(90 days), whichever came first. The rates of reinterven-
tion and death within 90 days of bariatric surgery were
estimated. To assess risk factors for these outcomes, mul-
tivariable Cox regression was used to calculate hazard
ratios (HRs) with 95 per cent confidence intervals. The
HRs were adjusted for each of the seven potential risk
factors categorized as described above, as well as country
(Denmark, Finland, Iceland, Norway or Sweden). Because
none of these factors correlated strongly, all were included
in the full multivariable model. Pairwise interaction terms
between all variables were tested. The proportionality
assumption was assessed using Schoenfeld residuals, and
was met for all variables except calendar year and the
surgery type vertical banded gastroplasty in relation to
mortality as a separate outcome. There were no missing
data for variables included in the models, because all
data were derived from well validated national registries.
All data management and statistical analyses followed a
detailed study protocol and were conducted by a senior
biostatistician, using Stata/MP™ version 15.1 (StataCorp,
College Station, Texas, USA).
Results
The bariatric surgery cohort included 49 977 patients
(Table 1). Of these, 1111 (2⋅2 per cent) underwent at least
one reintervention and 95 (0⋅2 per cent) died within 90 days
of surgery. Most of the bariatric surgery was conducted in
Sweden (72⋅1 per cent). The median age was 41⋅6 years and
© 2020 The Authors. British Journal of Surgery published by John Wiley & Sons Ltd www.bjs.co.uk BJS 2020; 107: 1221–1230
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Table 5 Adjusted hazard ratios for specific reinterventions after bariatric surgery
Hazard ratio*
Operative (n =827) Endoscopic (n =308) Percutaneous drainage (n = 72)
Age (years)
<30 1⋅00 (reference) 1⋅00 (reference) 1⋅00 (reference)
30–39 1⋅14 (0⋅90, 1⋅44) 0⋅75 (0⋅52, 1⋅10) 1⋅38 (0⋅58, 3⋅28)
40–49 1⋅35 (1⋅00, 1⋅75) 1⋅01 (0⋅70, 1⋅44) 1⋅69 (0⋅73, 3⋅91)
≥50 1⋅49 (1⋅05, 1⋅90) 1⋅70 (1⋅20, 2⋅43) 1⋅79 (0⋅75, 4⋅28)
Sex
M 1⋅00 (reference) 1⋅00 (reference) 1⋅00 (reference)
F 1⋅01 (0⋅86, 1⋅18) 0⋅92 (0⋅71, 1⋅18) 1⋅13 (0⋅67, 1⋅92)
Charlson co-morbidity index score
0 1⋅00 (reference) 1⋅00 (reference) 1⋅00 (reference)
1 1⋅33 (1⋅02, 1⋅73) 0⋅95 (0⋅60, 1⋅50) 1⋅29 (0⋅28, 2⋅85)
≥2 1⋅94 (0⋅86, 4⋅36) 1⋅27 (0⋅31, 5⋅15) 2⋅76 (0⋅37, 20⋅45)
Type of bariatric surgery
Gastric bypass 1⋅00 (reference) 1⋅00 (reference) 1⋅00 (reference)
Vertical banded gastroplasty 0⋅56 (0⋅42, 0⋅74) 1⋅92 (1⋅29, 2⋅86) 1⋅65 (0⋅52, 5⋅73)
Gastric banding 0⋅39 (0⋅29, 0⋅53) 0⋅24 (0⋅11, 0⋅52) 0⋅14 (0⋅02, 1⋅07)
Other bariatric procedures 1⋅08 (0⋅73, 1⋅58) 2⋅55 (1⋅47, 4⋅44) 6⋅99 (3⋅49, 14⋅00)
Malabsorptive procedures 1⋅40 (0⋅91, 2⋅16) 0⋅51 (0⋅13, 2⋅11) 1⋅64 (0⋅36, 7⋅46)
Surgical approach
Open 1⋅00 (reference) 1⋅00 (reference) 1⋅00 (reference)
Laparoscopic 1⋅14 (0⋅97, 1⋅79) 0⋅93 (0⋅68, 1⋅26) 0⋅42 (0⋅21, 0⋅85)
Year of surgery
Before 2000 1⋅00 (reference) 1⋅00 (reference) 1⋅00 (reference)
2000–2009 0⋅46 (0⋅34, 0⋅61) 3⋅27 (2⋅03, 5⋅27) 4⋅43 (1⋅34, 14⋅69)
2010 or later 0⋅37 (0⋅27, 0⋅51) 1⋅28 (0⋅74, 2⋅24) 5⋅38 (1⋅48, 19⋅53)
Values in parentheses are 95 per cent confidence intervals. One patient could have more than one type of reintervention. *Adjusted for country, age, sex,
Charlson comorbidity index, surgery type, surgical approach and year of surgery.
the majority of patients were women (74⋅5 per cent) and
without co-morbidity (93⋅3 per cent). The dominant type
of bariatric procedure was gastric bypass (73⋅4 per cent) and
the approach was mainly laparoscopic (72⋅8 per cent). The
median annual hospital volume was 12⋅8.
Risk of 90-day reintervention/mortality
Older age was associated with an increased risk of the com-
posite outcome reintervention/mortality within 90 days of
bariatric surgery (HR 1⋅65, 95 per cent c.i. 1⋅36 to 2⋅01,
for age at least 50 years versus less than 30 years), whereas
no risk difference was observed between the sexes (Table 2).
Co-morbidity was also associated with an increased risk
(HR 2⋅66, 1⋅53 to 4⋅62, for Charlson co-morbidity index
score 2 or more versus 0). Gastric banding was associ-
ated with a lower risk than gastric bypass (HR 0⋅37, 0⋅28
to 0⋅48). There was no significant association between
the laparoscopic and open approach (HR 0⋅87, 0⋅73 to
1⋅04). The risk of reintervention/mortality decreased with
calendar interval of surgery; the HRwas 0⋅77 (0⋅61 to 0⋅97)
in 2000–2009 and 0⋅51 (0⋅39 to 0⋅67) from 2010 onwards,
compared with the interval before 2000. Higher hospital
volume was not associated with a significantly decreased
risk of 90-day reintervention/mortality (HR 0⋅80, 0⋅61
to 1⋅07, for highest versus lowest tertile) (Table 2). The
addition of hospital volume to the adjusted analysis did
not change the risk estimates for the other potential risk
factors studied (Table S2, supporting information).
The stratified analyses showed some statistically signif-
icant interactions (Table 3). Among patients who had an
open surgical procedure, women had a decreased risk of
reintervention/mortality compared with men (HR 0⋅66,
0⋅54 to 0⋅82), whereas no sex difference was observed
for patients who had laparoscopic surgery. More recent
surgery was associated with a decreased risk of reinter-
vention/mortality in the laparoscopic surgery group (HR
0⋅37, 0⋅23 to 0⋅61, for 2010 onwards versus before 2000),
but not in the open surgery group (HR 0⋅91, 0⋅60 to 1⋅37)
(Table 3).
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Risk of 90-day reintervention
Reinterventions were more common than deaths, and the
results for reinterventions alone were similar to those for
the composite variable reintervention/mortality. Increas-
ing age, co-morbidity, other bariatric surgery, and earlier
year of surgery were risk factors, but sex and surgical
approach were not (Table 4).
Of the 1111 patients who had any reintervention, 827
(74⋅4 per cent) had operative reintervention, 308 (27⋅7
per cent) had endoscopic reintervention, 72 (6⋅5 per cent)
had percutaneous reintervention and 17 (1⋅5 per cent)
underwent tracheostomy. These groups of reinterventions
were analysed separately, except for tracheostomy because
of the small number of patients requiring this. Older age
increased the risk of operative and endoscopic reinterven-
tions, whereas sex did not influence the risk of any type
of reintervention (Table 5). Co-morbidity increased the
risk of operative reintervention. Compared with gastric
bypass, vertical banded gastroplasty was associated with a
decreased risk of operative reintervention, but an increased
risk of endoscopic reintervention. Gastric banding was
associated with a lower risk of each type of reintervention
than gastric bypass. Laparoscopic surgery was associated
with a decreased risk of percutaneous reintervention
compared with open surgery. During more recent years,
the risk of operative intervention decreased, whereas the
risk of percutaneous intervention increased (Table 5).
Risk of 90-day mortality
Older age was associated with an increased risk of death
within 90 days (HR 5⋅57, 95 per cent c.i. 2⋅18 to 14⋅24,
for age at least 50 versus less than 30 years), and women
had lower risk than men (HR 0⋅57, 0⋅37 to 0⋅86) (Table 4).
Co-morbidity was associated with an increased risk (HR
9⋅48, 3⋅33 to 26⋅99, Charlson co-morbidity index 2 or
more versus 0). Compared with gastric bypass, both verti-
cal banded gastroplasty (HR 0⋅43, 0⋅21 to 0⋅86) and gastric
banding (HR 0⋅18, 0⋅08 to 0⋅44) were associated with a
decreased risk. The laparoscopic approach was associated
with a lower risk than the open approach (HR 0⋅29, 0⋅16
to 0⋅53). The risk of death was lower during more recent
years (HR 0⋅20, 0⋅09 to 0⋅47, for 2010 onwards versus
before 2000).
Discussion
This study showed a low incidence of 90-day reinterven-
tion and mortality after bariatric surgery in an unselected
cohort in the Nordic countries. Risk factors for the
composite outcome reintervention/mortality, as well as
reinterventions and death analysed separately, were older
age and co-morbidity, whereas female sex was associated
with a decreased risk of death. Among surgical factors,
the laparoscopic approach did not influence the risk of
reintervention/mortality, but decreased the risk of death.
Gastric bypass was followed by an increased risk of all
outcomes compared with other bariatric procedures. The
incidence of 90-day reintervention andmortality decreased
over time.
Strengths of the study include the population-based
design, large sample size, and complete data on bariatric
surgery, potential risk factors, reinterventions and
mortality. Numerous studies23–27 have verified the high
quality of the data in the registers used. The Nordic pop-
ulations share sociodemographic characteristics, genetic
background, cultural traditions and norms, and have sim-
ilar and publicly funded healthcare, social and population
registration systems, and overall mortality rates. The
BMI and co-morbidity requirements for consideration of
bariatric surgery were similar in these countries during
the study interval: BMI over 40 kg/m2, or BMI exceeding
35 kg/m2 and at least one obesity-related co-morbidity35,36.
Therefore, combining data from these countries should
not introduce much heterogeneity, but increase the sample
size and facilitate generalizability21. Because the reporting
of surgical procedures to the national patient registries is
mandatory by law and hospital reimbursement depends on
this reporting, the completeness of registration of bariatric
surgery is high. The main limitation is confounding,
although the adjustment for several confounders should
reduce such bias. Yet, there was a lack of data on some
relevant variables that could not be assessed, particularly
BMI, and also tobacco smoking and alcohol overcon-
sumption. However, individuals selected for bariatric
surgery constitute a relatively homogeneous group regard-
ing BMI35, and smoking and alcohol consumption were
adjusted for indirectly using the Charlson co-morbidity
index. Indications, techniques and devices used in bariatric
surgery have evolved over the long study period, leading
to changes in patient selection, including the proportion
of co-morbidities. Therefore, the adjustment for calendar
period of surgery was relevant. Although some procedures
are currently not in use, the authors wanted to provide a
comprehensive study showing the entire picture without
exclusion of certain bariatric procedures. Five different
bariatric surgery procedures were also analysed separately.
Moreover, the period of surgery was taken into account,
reducing confounding caused by these changes. Another
weakness is the lack of data on sleeve gastrectomy, which
has become increasingly common since the time period of
the present study.
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Most studies examining short-term outcomes of bariatric
surgery have focused on 30-day outcomes. A multicen-
tre study13 of 4776 patients reported a 4⋅1 per cent
incidence of the composite outcome postoperative com-
plications/reoperations/failure to discharge/death within
30 days of bariatric surgery, whereas abdominal reopera-
tions were undertaken in 2⋅6 per cent of patients and 0⋅3
per cent died. Poor functional status, history of deep vein
thrombosis and sleep apnoea and gastric bypass (compared
with gastric banding) were risk factors for the composite
outcome. A meta-analysis15 of 38 RCTs, including 4030
patients, reported a 30-day mortality rate of 0⋅18 per cent
after bariatric surgery. This might not mirror clinical prac-
tice, however, because of the inclusion criteria of these
trials. Additionally, the small sample size of these studies
was a limitation13,15. In a large register-based study16 of
96 538 patients undergoing bariatric surgery, 1⋅9 per cent
had reintervention within 30 days of operation, and risk
factors were age over 65 years, male sex, ASA grade above
II, history of smoking, co-morbidity and poor functional
status. In another large register-based study17 of 243 747
patients, co-morbidity, smoking and high ASA grade were
associated with an increased risk of reintervention within
30 days of bariatric surgery.
In contrast, the incidence of, and risk factors for, 90-day
reintervention ormortality in patients undergoing bariatric
surgery are less clear. Modern postoperative intensive
care and perioperative management of surgical patients
may reduce or postpone death from complications beyond
30 days, making 90-day outcomes more relevant in the
modern era. The only previous large-scale study14 exam-
ining 90-day outcomes after bariatric surgery was a large
retrospective analysis of 297 688 patients that focused on
centralization, but also showed that male sex, older age,
co-morbidity and lower hospital volume were risk factors
for death. However, that study did not examine reinterven-
tion, which was the main outcome of the present study.
The present results indicate that increasing age and
co-morbidity are associated with an increased risk of re-
intervention and death within 90 days of bariatric surgery.
These findings are in line with studies examining risk fac-
tors for 30-day reinterventions and mortality14,15. Sex was
not identified as a risk factor for reintervention here, but
women had lower risk of death than men. The typical
male body fat distribution is centred around the abdomen.
Speculatively, it could make open surgery more demand-
ing in men than in women, whereas this may be of less
concern in laparoscopic bariatric surgery. Furthermore,
sex differences in lifestyle factors and health consciousness
may influence the severity and consequences of complica-
tions, which could explain the higher mortality rate in men.
The decreased risk of reintervention/mortality after gas-
tric banding compared with gastric bypass has also been
suggested previously13,15. Gastric banding was associated
with a decreased risk of all reinterventions, whereas vertical
banded gastroplasty was associated with an increased risk
of endoscopic intervention, compared with gastric bypass.
This could reflect differences in complexity of these proce-
dures; gastric banding does not include any major recon-
struction or anastomosis. Compared with open surgery,
the laparoscopic approach was not associated with any
decreased risk of reintervention in general, but it reduced
the need for percutaneous interventions and risk of death.
The generally decreased risk of reintervention/mortality
more recently is encouraging, indicating improvements
over time. Another time trend was the shift from more
operative reinterventions in the earlier time interval to
an increased use of percutaneous and endoscopic rein-
terventions. Modern imaging techniques have reduced
the need for exploratory surgery and enabled more tail-
ored percutaneous interventions. It has been reported
that high-volume bariatric surgery centres have lower
short-term mortality rates than low-volume centres8,
which suggests that increasing experience of surgeons and
frequency of bariatric procedures over time reduces the
need for reintervention and risk of postoperative death.
However, the volume–outcome association in compli-
cation risk after bariatric surgery is under debate, and
surgery in higher-volume centres was not associated with
any clearly decreased risk of reintervention/mortality
in the present study, although the point estimate was
decreased and there were few really high-volume centres.
The volume–outcome association was assessed in only
three of the five countries, but the analysis still included
over 80 per cent of the patients in the cohort; estimates
for other risk factors were unchanged after adjusting for
hospital volume, supporting the validity of these find-
ings. Higher-volume centres (often university clinics in
Nordic countries) may more frequently operate on more
vulnerable patients (extremely obese patients and those
with more co-morbidity), which could explain the lack of
a clear association in the present study. It is also possible
that relatively few higher-volume surgeons undertake
bariatric surgery in the lower-volume hospitals, whereas
the individual surgeon volume could be relatively low in
the higher-volume hospitals.
Some of the present findings might be helpful in clin-
ical practice. Although operating on patients aged over
50 years with multiple co-morbidities is associated with
an increased relative risk of poor postoperative outcomes,
the absolute risk is still low. Of patients aged over 50 years
and with any co-morbidity undergoing gastric bypass,
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3⋅6 per cent experienced reintervention/mortality within
90 days of surgery, compared with 2⋅4 per cent among all
other patients. Nevertheless, preoperative optimization of
health status and meticulous follow-up during the initial
postoperative period are recommended. Further research
is needed to clarify the volume–outcome association
in bariatric surgery, especially examining surgeon vol-
ume, and the risk of reintervention/mortality after sleeve
gastrectomy.
This population-based cohort study with data from five
countries showed a low absolute risk of reintervention
and mortality within 90 days of bariatric surgery, which
decreased over the study period. The main patient risk fac-
tors are older age and co-morbidity. Sex, surgical approach
(laparoscopic versus open) and hospital volume did not
influence the risk, although female sex and laparoscopic
approach were associated with decreased risk of 90-day
mortality.
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